Scleroderma with type III glomerulonephritis and MPO-ANCA antibodies in the serum

Journal of the European Academy of Dermatology and Venereology

Volumn 19, Issue 5, 2005, Pages 617-620

  Herrera Esparza, R ^a   Aguilar, J L ^a   Saucedo, A ^a   Gonzalez I ^a   Lopez Robles E ^a   Avalos Diaz E ^a  

^a NONE

Author keywords

Anticentromere antibodies; CREST; Glomerulonephritis; MPO; pANCA

Indexed keywords

CENTROMERE ANTIBODY; COMPLEMENT COMPONENT C3; CYCLOPHOSPHAMIDE; ENALAPRIL; FUROSEMIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHYLPREDNISOLONE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADULT; ANAMNESIS; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; FEMALE; GLOMERULONEPHRITIS; HUMAN; KIDNEY BIOPSY; LABORATORY TEST; PRIORITY JOURNAL; SCLERODERMA; SYNDROME CREST; THORAX RADIOGRAPHY; TREATMENT OUTCOME; ULTRASOUND;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOPSY, NEEDLE; CREST SYNDROME; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOHISTOCHEMISTRY; METHYLPREDNISOLONE; MIDDLE AGED; PEROXIDASE; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 28544446484     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2005.01231.x     Document Type: Article

References (20)

1. Thibierge G, Weissenbach RJ. Concretions calcaires sous-cutanees et sclerodermie. Ann Derm Syph 1911; 2: 129-155.
2. Winterbauer RH. Multiple telangiectasia, Raynaud's phenomenon, sclerodactyly and subcutaneous calcinosis: a syndrome mimicking hereditary hemorrhagic telangiectasia. Bull Johns Hopkins Hosp 1964; 114: 361-383.
3. Velayos EE, Masi AT, Stevens MB, Shulman LE. The 'CREST' syndrome: comparison with systemic sclerosis (scleroderma). Arch Intern Med 1979; 139: 1240-1244.
4. Ho KT, Reveille JD. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 2003; 5: 80-93.
5. Oddis CV, Okano Y, Rudert WA et al. Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations. Arthritis Rheum 1992; 35: 1211-1217.
6. Herrera-Esparza R, Kruse L, von Essen M et al. U3 snoRNP associates with fibrillarin, a component of the scleroderma clumpy nucleolar domain. Arch Dermatol Res 2002; 294: 310-317.
7. Yang JM, Hildebrandt B, Luderschmidt C, Pollard KM. Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex. Arthritis Rheum 2003; 48: 210-217.
8. Reddy R, Tan EM, Henning D, Nohga K, Busch H. Detection of a nucleolar 7-2 ribonucleoprotein and a cytoplasmic 8-2 ribonucleoprotein with autoantibodies from patients with scleroderma. J Biol Chem 1983; 258: 1383-1386.
9. Reimer G, Rose KM, Scheer U, Tan EM. Autoantibody to RNA polymerase I in scleroderma sera. J Clin Invest 1987; 79: 65-72.
10. Cannon PJ, Hassar M, Case DB et al. The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Medicine (Baltimore) 1974; 53: 1-46.
11. Katrib A, Sturgess A, Bertouch JV. Systemic sclerosis and antineutrophil cytoplasmic autoantibody-associated renal failure. Rheumatol Int 1999; 19: 61-63.
12. Anders HJ, Wiebecke B, Haedecke C et al. MPO-ANCA-positive crescentic glomerulonephritis: a distinct entity of scleroderma renal disease? Am J Kidney Dis 1999; 33: e3.
13. Locke IC, Worrall JG, Leaker B, Black CM, Cambridge G. Autoantibodies to myeloperoxidase in systemic sclerosis. J Rheumatol 1997; 24: 86-89.
14. Miyata N, Kobayashi T, Matsukawa Y et al. Anti-neutrophil cytoplasmic autoantibody-associated rapid progressive glomerulonephritis complicated with both limited and diffuse scleroderma. Nihon Rinsho Meneki Gakkai Kaishi 2002; 25: 473-479.
15. Salach RK, Cash JM. Managing lupus nephritis: algorithms for conservative use of renal biopsy. Cleve Clin J Med 1996; 63: 106-115.
16. Bellisai F, Morozzi G, Bacarelli MR et al. Anti-proteinase 3 antibodies in diffuse systemic sclerosis (SSc) with normotensive renal impairment: is it suggestive for an overlapping between SSc and idiopathic vasculitis? Reumatismo 2001; 53: 33-39.
17. Puszczewicz M, Zimmermann-Gorska I, Bialkowska-Puszczewicz G, Tuchocka A. Prevalence and specificity of antineutrophil cytoplasmic antibodies (ANCA) in connective tissue diseases. Pol Arch Med Wewn 2003; 109: 35-41.
18. Ruffatti A, Sinico RA, Radice A et al. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis. J Rheumatol 2002; 29: 918-923.
19. Yamashita K, Yorioka N, Kyuden Y et al. A case of CREST syndrome and myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis. Clin Nephrol 2000; 53: 296-300.
20. Maes B, Van Mieghem A, Messiaen T et al. Limited cutaneous systemic sclerosis associated with MPO-ANCA positive renal small vessel vasculitis of the microscopic polyangiitis type. Am J Kidney Dis 2000; 36: E16.